Today's noteworthy initiations include: AMAG Pharmaceuticals (AMAG) initiated with an Outperform at Northland... Angie's List (ANGI) initiated with a Neutral at Roth Capital... Bio Blast Pharma (ORPN) initiated with a Buy at Rodman & Renshaw... British American Tobacco (BTI) initiated with a Buy at UBS... Imperial Tobacco (ITYBY) initiated with a Buy at UBS... Instructure (INST) initiated with an Outperform at Barrington... Nektar (NKTR) initiated with a Buy at Janney Capital... Par Pacific (PARR) initiated with an Outperform at Imperial Capital... Pure Storage (PSTG) initiated with a Buy at Maxim... comScore (SCOR) initiated with a Hold at Evercore ISI.

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here

Morgan Stanley lowered the firm's price target on Instructure (INST) to $28 from $31 and keeps an Overweight rating on the shares. While the firm's fundamental estimates are unchanged, it has updated valuation multiples to reflect compression in the Education Software peer group, noting that revenue and EBITDA multiples are down low-double digits on average since last earnings. Among the group, the firm says it favors Docebo (DCBO) and Coursera (COUR) as it sees them with "the cleanest stories" and best likelihood for positive estimate revisions, which at odds with their discounted valuations.

180 Degree Capital (TURN) noted the filing of a proxy statement by comScore (SCOR) that includes Matthew McLaughlin as a nominee for election to SCOR's Board of Directors at its upcoming 2024 Annual Meeting of Stockholders. In conjunction with this filing, 180 Degree Capital formally withdrew its nomination of McLaughlin as well as its proposal to declassify SCOR's Board of Directors.